reversible ATX inhibitor w/ alt. binding mode

in vivo PD observed on oral dosing

from HTS screen and opt.

Bioorg. Med. Chem. Lett., Nov. 4, 2020

Novartis, Horsham, UK / Basel, CH

Structure of compound 15a

“compound 15a” (Novartis reversible in vivo ATX inhibitor)

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: